Adjuvant TACE to Reduce the HCC Recurrence After Resection

Clinical Trial ID NCT02788526

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02788526

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 2009 1.12
2 Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995 0.87
3 Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus. Hepatogastroenterology 2006 0.81
4 [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection]. Zhonghua Zhong Liu Za Zhi 1994 0.75
Next 100